Evidence map›Paper›PMID 28369627›Full record

ArticleNucleic acids research2017

Engineering microbial phenotypes through rewiring of genetic networks.

Oliver P F Windram, Rui T L Rodrigues, Sangjin Lee, Matthew Haines, Travis S Bayer

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Oliver P F WindramCentre for Synthetic Biology and Innovation and Department of Life Sciences, Imperial College London, London SW7 2AZ, UK.
Rui T L RodriguesCentre for Synthetic Biology and Innovation and Department of Life Sciences, Imperial College London, London SW7 2AZ, UK.
Sangjin LeeCentre for Synthetic Biology and Innovation and Department of Life Sciences, Imperial College London, London SW7 2AZ, UK.
Matthew HainesCentre for Synthetic Biology and Innovation and Department of Life Sciences, Imperial College London, London SW7 2AZ, UK.
Travis S BayerCentre for Synthetic Biology and Innovation and Department of Life Sciences, Imperial College London, London SW7 2AZ, UK.
Imperial College London · GB

Funding

Polyamine Based Therapy of Squamous Cell CarcinomaR01CA094107 · NCI · LANKENAU INSTITUTE FOR MEDICAL RESEARCH · PI O'BRIEN, THOMAS G · 2002 to 2008
$2.3M
NCI NIH HHS R01 CA094107
6 · The paper itself

Abstract

The ability to program cellular behaviour is a major goal of synthetic biology, with applications in health, agriculture and chemicals production. Despite efforts to build 'orthogonal' systems, interactions between engineered genetic circuits and the endogenous regulatory network of a host cell can have a significant impact on desired functionality. We have developed a strategy to rewire the endogenous cellular regulatory network of yeast to enhance compatibility with synthetic protein and metabolite production. We found that introducing novel connections in the cellular regulatory network enabled us to increase the production of heterologous proteins and metabolites. This strategy is demonstrated in yeast strains that show significantly enhanced heterologous protein expression and higher titers of terpenoid production. Specifically, we found that the addition of transcriptional regulation between free radical induced signalling and nitrogen regulation provided robust improvement of protein production. Assessment of rewired networks revealed the importance of key topological features such as high betweenness centrality. The generation of rewired transcriptional networks, selection for specific phenotypes, and analysis of resulting library members is a powerful tool for engineering cellular behavior and may enable improved integration of heterologous protein and metabolite pathways.

Indexed as

Genetic EngineeringSynthetic BiologyGene Expression RegulationGene Regulatory NetworksHumansMetabolic EngineeringNitrogenPhenotypeSaccharomyces cerevisiaeTerpenesNitrogenTerpenes

Identifiers

PMID28369627
PMCPMC5416768
OpenAlexW2599840325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.